Filing Details
- Accession Number:
- 0001127602-22-020005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-01 16:13:38
- Reporting Period:
- 2022-08-01
- Accepted Time:
- 2022-08-01 16:13:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1062822 | Lexicon Pharmaceuticals Inc. | LXRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1053890 | Raymond Debbane | 2445 Technology Forest Blvd. 11Th Floor The Woodlands TX 77381 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-01 | 982,600 | $2.50 | 5,303,814 | No | 4 | P | Indirect | By Invus US Partners LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Invus US Partners LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 331,545 | Direct |
Billionaire Hedge Funds
